Travere Therapeutics, Inc. (TVTX) › Shares OutstandingTravere Therapeutics, Inc. (TVTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 4.04M2012: 8.95M2013: 18.42M2014: 26.05M2015: 36.47M2016: 37.91M2017: 39.37M2018: 41.39M2019: 43.09M2020: 52.25M2021: 62.49M2022: 64.29M2023: 75.37M2024: 87.45M2025: 90.92M90.92M2011Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202590.92M+4.0%202487.45M+16.0%202375.37M+17.2%202264.29M+2.9%202162.49M+19.6%202052.25M+21.3%201943.09M+4.1%201841.39M+5.1%201739.37M+3.9%201637.91M+4.0%201536.47M+40.0%201426.05M+41.4%201318.42M+105.7%20128.95M+121.5%20114.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share